Corticosteroids and Sarcoidosis

Corticosteroids are commonly used when sarcoidosis causes significant or progressive inflammation. They may improve symptoms and protect organ function, but long-term treatment can cause weight gain, high blood pressure, diabetes, osteoporosis, infection risk and other side effects.

The dose should be adjusted gradually by a doctor. Never stop corticosteroids suddenly without medical advice.

Corticosteroids (CS) are considered a first-line therapeutic approach because of their strong and rapid anti-inflammatory action. CS have various mechanisms of action, including inhibition of TNF-α, INF-γ and related signalling pathways, such as NF-κB.

However, the optimal therapeutic dose and duration of treatment are not standardised because of a lack of adequate randomised controlled clinical trials. When used in the short term, CS can dramatically improve disease-related symptoms, normalise molecular biomarkers, and restore lung function and X-ray findings.

However, their long-term effects and benefits are unclear because they often fail to slow disease progression or prevent fibrosis, and there is no evidence that they improve survival.

CS have numerous side effects, which contribute to a lower perceived quality of life among patients treated with CS compared with untreated patients who have similar disease manifestations. Despite their unfavourable side-effect profile, CS remain the most commonly used first-line therapy, especially in acute, life-threatening or symptomatic disease.

Rating: 0 stars, 0 votes.